These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 2136623)

  • 1. Efficacy of nalbuphine as a parenteral analgesic for the treatment of painful episodes in children with sickle cell disease.
    Woods GM; Parson PM; Strickland DK
    J Assoc Acad Minor Phys; 1990; 1(3):90-2. PubMed ID: 2136623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opioid selection during sickle cell pain crisis and its impact on the development of acute chest syndrome.
    Buchanan ID; Woodward M; Reed GW
    Pediatr Blood Cancer; 2005 Oct; 45(5):716-24. PubMed ID: 15926170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of parenteral narcotic choice in the development of acute chest syndrome in sickle cell disease.
    Lewing K; Britton K; DeBaun M; Woods G
    J Pediatr Hematol Oncol; 2011 May; 33(4):255-60. PubMed ID: 21464764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emergency department management of acute pain episodes in sickle cell disease.
    Tanabe P; Myers R; Zosel A; Brice J; Ansari AH; Evans J; Martinovich Z; Todd KH; Paice JA
    Acad Emerg Med; 2007 May; 14(5):419-25. PubMed ID: 17389246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient-controlled analgesia pain management for children with sickle cell disease.
    Holbrook CT
    J Assoc Acad Minor Phys; 1990; 1(3):93-6. PubMed ID: 2136624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-dose intravenous methylprednisolone therapy for pain in children and adolescents with sickle cell disease.
    Griffin TC; McIntire D; Buchanan GR
    N Engl J Med; 1994 Mar; 330(11):733-7. PubMed ID: 8107739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in sleep, food intake, and activity levels during acute painful episodes in children with sickle cell disease.
    Jacob E; Miaskowski C; Savedra M; Beyer JE; Treadwell M; Styles L
    J Pediatr Nurs; 2006 Feb; 21(1):23-34. PubMed ID: 16428011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are there phases to the vaso-occlusive painful episode in sickle cell disease?
    Jacob E; Beyer JE; Miaskowski C; Savedra M; Treadwell M; Styles L
    J Pain Symptom Manage; 2005 Apr; 29(4):392-400. PubMed ID: 15857743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How French paediatric emergency departments manage painful vaso-occlusive episodes in sickle cell disease patients.
    Galeotti C; Courtois E; Carbajal R
    Acta Paediatr; 2014 Dec; 103(12):e548-54. PubMed ID: 25130719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of uncomplicated vaso-occlusive crises in children with sickle cell disease in a day hospital.
    Raphael JL; Kamdar A; Beavers MB; Mahoney DH; Mueller BU
    Pediatr Blood Cancer; 2008 Jul; 51(1):82-5. PubMed ID: 18383165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retrospective evaluation of pain assessment and treatment for acute vasoocclusive episodes in children with sickle cell disease.
    Zempsky WT; Loiselle KA; McKay K; Blake GL; Hagstrom JN; Schechter NL; Kain ZN
    Pediatr Blood Cancer; 2008 Aug; 51(2):265-8. PubMed ID: 18386784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantification of analgesic use in children with sickle cell disease.
    Jacob E; Miaskowski C; Savedra M; Beyer JE; Treadwell M; Styles L
    Clin J Pain; 2007 Jan; 23(1):8-14. PubMed ID: 17277639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Painful crises in children with sickle cell disease are not prevented by piracetam.
    Viana MB; Alvim RC
    Acta Haematol; 2009; 121(1):9-10. PubMed ID: 19246889
    [No Abstract]   [Full Text] [Related]  

  • 14. [Sickle cell disease pain management following the World Health Organization's protocol].
    Moussavou A; Vierin Y; Eloundou-Orima C; Mboussou M; Keita M
    Arch Pediatr; 2004 Sep; 11(9):1041-5. PubMed ID: 15350992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute pancreatitis during sickle cell vaso-occlusive painful crisis.
    Ahmed S; Siddiqui AK; Siddiqui RK; Kimpo M; Russo L; Mattana J
    Am J Hematol; 2003 Jul; 73(3):190-3. PubMed ID: 12827657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical practice guideline improves the treatment of sickle cell disease vasoocclusive pain.
    Morrissey LK; Shea JO; Kalish LA; Weiner DL; Branowicki P; Heeney MM
    Pediatr Blood Cancer; 2009 Mar; 52(3):369-72. PubMed ID: 19023890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haemorheological treatment of painful sickle cell crises. Use of pentoxifylline.
    Poflee VW; Gupta OP; Jain AP; Jajoo UN
    J Assoc Physicians India; 1991 Aug; 39(8):608-9. PubMed ID: 1814876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of acute pain crisis on exhaled nitric oxide levels in children with sickle cell disease.
    Pawar SS; Panepinto JA; Brousseau DC
    Pediatr Blood Cancer; 2008 Jan; 50(1):111-3. PubMed ID: 16619223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute splenic sequestration crisis in children with sickle cell disease.
    Al-Hawsawi ZM; Ismail GA
    Saudi Med J; 2001 Dec; 22(12):1076-9. PubMed ID: 11802180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary hyperparathyroidism mimicking vaso-occlusive crises in sickle cell disease.
    Krishnamoorthy P; Alyaarubi S; Abish S; Gale M; Albuquerque P; Jabado N
    Pediatrics; 2006 Aug; 118(2):e537-9. PubMed ID: 16882790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.